Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Uterine papillary serous carcinoma
Email alerts
Uterine papillary serous carcinoma
The Risk of Subsequent Malignancies in Women With Uterine Papillary Serous or Clear Cell Endometrial Cancers
Hilary D.
Hinshaw
,
Ashlee
Smith
,
Bunja
Rungruang
,
Joseph L.
Kelley
,
Sushil
Beriwal
,
Thomas C.
Krivak
,
Paniti
Sukumvanich
,
Alexander B.
Olawaiye
International Journal of Gynecologic Cancer
Jul 2013,
23
(6)
1044-1049;
DOI:
10.1097/IGC.0b013e3182959053
Does the FIGO 2009 Endometrial Cancer Staging System More Accurately Correlate With Clinical Outcome in Different Histologies? Revised Staging, Endometrial Cancer, Histology
Brandi R.
Page
,
Lisa
Pappas
,
Ellen Ware
Cooke
,
David K.
Gaffney
International Journal of Gynecologic Cancer
May 2012,
22
(4)
593-598;
DOI:
10.1097/IGC.0b013e3182412ebd
Role of Adjuvant Chemotherapy in Patients With Early Stage Uterine Papillary Serous Cancer
Ali
Mahdavi
,
Tania R.
Tajalli
,
Ahmed
Dalmar
,
Steven A.
Vasilev
,
Scott E.
Lentz
,
Michael L.
Berman
International Journal of Gynecologic Cancer
Nov 2011,
21
(8)
1436-1440;
DOI:
10.1097/IGC.0b013e31822e7588
Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
J. S.
Kwon
,
J.
Abrams
,
A.
Sugimoto
,
M. S.
Carey
International Journal of Gynecologic Cancer
Jul 2008,
18
(4)
820-824;
DOI:
10.1136/ijgc-00009577-200807000-00033
Complete response to docetaxel and carboplatin combination chemotherapy for a stage IV uterine papillary serous carcinoma: a case report
K.
KASHIMA
,
Y.
AOKI
,
T.
YAHATA
,
K.
TANAKA
International Journal of Gynecologic Cancer
Nov 2005,
15
(6)
1199-1202;
DOI:
10.1136/ijgc-00009577-200511000-00039
Combined Chemotherapy Regimen of Carboplatin and Paclitaxel as Adjuvant Treatment for Papillary Serous and Clear Cell Endometrial Cancer
Gil
Shechter-Maor
,
Ilan
Bruchim
,
Zipi
Ben-Harim
,
Marco
Altaras
,
Ami
Fishman
International Journal of Gynecologic Cancer
Apr 2009,
19
(4)
662-664;
DOI:
10.1111/IGC.0b013e3181a3d626
Pages
« first
‹ previous
1
2
Special collections
Editor's choice
(186)
Guidelines, Recommendations and Consensus Statements
IJGC
Case Study
(17)
Cervical Cancer
(20)
Clinical Trial
(108)
Corners of the World
(23)
Endometrial Cancer
Fertility and Pregnancy
Lay summaries
(1)
Lead articles
(13)
Ovarian Cancer
(35)
Palliative Care
Perioperative Care
Preinvasive Disease
(1)
Review
(28)
Surgical Outcomes
Uterine Cancer
(16)
Video Article
(178)
Vulvar Cancer
(2)
Open access
(269)
Press releases
(4)
